semaglutide compound ending Patients struggle as compounded GLP-1 access rapidly shrinks Novo Nordisk's semaglutide shortage officially

This new class of medications, known as GP1-inhibitors, is rapidly growing to be a leading solution for weight management

The term had circulated in patient communities and across TikTok for years, but it reached a mass audience in 2024, when Oprah Winfrey devoted a primetime special, "Shame, Blame and the Weight Loss Revolution," to weight-loss medications and spoke candidly about how they quieted her own food noise

Design of programmable post-translational switch control platform for on-demand protein secretion in mammalian cells

Most patients follow a predictable path to help their bodies adjust to the medication